Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. 2002

F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
Centre of Nuclear Medicine, University of Louvain Medical School, Brussels, Belgium.

OBJECTIVE We previously described a novel radiolabelled monoclonal antibody (1.2B6), which reacts with porcine E-selectin, for targeting activated endothelium as a means of imaging inflammatory disorders, and presented initial clinical work based on (111)In-labelled antibody. The aim of the present study was to evaluate a Fab fragment of 1.2B6 labelled with (99m)Tc in patients with rheumatoid arthritis (RA) by comparison with (i) (111)In-labelled 1.2B6 F(ab')(2) and (ii) conventional bone scanning. METHODS (99m)Tc-1.2B6-Fab ( approximately 440 MBq) and (111)In-1.2B6-F(ab')(2) ( approximately 27 MBq) were compared in 10 patients using a double-isotope protocol. Images were obtained 4 and 20-24 h after injection. Two normal volunteers were also imaged. In a separate group of 16 patients, (99m)Tc-1.2B6-Fab and (99m)Tc-oxidronate ((99m)Tc-HDP) ( approximately 740 MBq) were compared on the basis of visual and semi-quantitative analysis of joint uptake (joint/soft tissue ratios) 4 h after injection. The respective biodistributions and blood clearances of the two 1.2B6 fragments were also compared. RESULTS Image contrast was slightly better with (99m)Tc-Fab at 4 h but equal for the two tracers at 24 h. Diagnostic accuracy, taking joint tenderness or swelling as the clinical endpoint, was 76% for both fragments at 24 h. Plasma clearance of (99m)Tc-Fab was faster than that of (111)In-F(ab')(2) (t(1/2) 142 vs 421 min; P<0.0001). (99m)Tc-Fab appeared somewhat unstable in vivo, as shown by activity in the thyroid gland and bowel. The diagnostic accuracy of (99m)Tc-Fab was 88%, higher than that of (99m)Tc-HDP (57%) as a result of the low specificity of the latter in RA. Receiver operating characteristic (ROC) curve analysis using joint/soft tissue ratios as a variable cut-off showed that (99m)Tc-Fab discriminates better than (99m)Tc-HDP between actively inflamed and silent joints (Z=4.72; P<0.0001). No uptake of (99m)Tc-Fab was observed by inactive or normal joints, whereas (99m)Tc-HDP was taken up by all joints to a variable degree, making the decision as to whether a particular joint is actively involved or chronically damaged very difficult. CONCLUSIONS (99m)Tc-anti-E-selectin-Fab scintigraphy can be used successfully to image synovitis with better specificity than (99m)Tc-HDP bone scanning. The advantages over (111)In-1.2B6-F(ab')(2) are easier availability of the radionuclide, improved physical properties and optimal imaging 4 h after injection.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
January 1996, Scandinavian journal of rheumatology,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
January 1969, Nordisk medicin,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
December 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
February 1994, European journal of nuclear medicine,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
November 1986, British medical journal (Clinical research ed.),
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
February 1993, Nuclear medicine communications,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
January 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
April 2002, European journal of nuclear medicine and molecular imaging,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
January 1999, Nuklearmedizin. Nuclear medicine,
F Jamar, and F A Houssiau, and J-P Devogelaer, and P T Chapman, and D O Haskard, and V Beaujean, and C Beckers, and D-H Manicourt, and A M Peters
October 1972, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Copied contents to your clipboard!